Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 331 results.
User Information
Export Records
  1. 1.   The Janus kinase 1 is critical for pancreatic cancer initiation and progression
  2. Shrestha, Hridaya; Rädler, Patrick D; Dennaoui, Rayane; Wicker, Madison N; Rajbhandari, Nirakar; Sun, Yunguang; Peck, Amy R; Vistisen, Kerry; Triplett, Aleata A; Beydoun, Rafic; Sterneck,Esta; Saur, Dieter; Rui, Hallgeir; Wagner, Kay-Uwe
  3. Cell Reports. 2024, May 10; 43(5): 114202.
  1. 2.   The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia
  2. Liu,Yonglan; Jang,Hyunbum; Zhang,Mingzhen; Tsai,Chung-Jung; Maloney,Ryan; Nussinov,Ruth
  3. Biophysical Journal. 2022, May 31;
  1. 3.   ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
  2. Su, Wenjing; Mukherjee, Radha; Yaeger, Rona; Son, Jieun; Xu, Jianing; Na, Na; Merna Timaul, Neilawattie; Hechtman, Jaclyn; Paroder, Viktoriya; Lin, Mika; Mattar, Marissa; Qiu, Juan; Chang, Qing; Zhao, Huiyong; Zhang, Jonathan; Little, Megan; Adachi, Yuta; Han, Sae-Won; Taylor, Barry S; Ebi, Hiromichi; Abdel-Wahab, Omar; de Stanchina, Elisa; Rudin, Charles M; Jänne, Pasi A; McCormick, Frank; Yao, Zhan; Rosen, Neal
  3. Molecular Cell. 2022, May 14;
  1. 4.   A molecular mechanism for the generation of ligand-dependent differential outputs by the epidermal growth factor receptor
  2. Huang, Yongjian; Ognjenovic,Jana; Karandur, Deepti; Miller, Kate; Merk,Alan; Subramaniam, Sriram; Kuriyan, John
  3. eLife. 2021, Nov 30; 10
  1. 5.   Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer
  2. Choudhary, Shruti; Doshi, Arpit; Luckett-Chastain, Lerin; Ihnat, Michael; Hamel,Ernest; Mooberry, Susan L.; Gangjee, Aleem
  3. Bioogranic & Medicinal Chemistry. 2021, Apr 1; 35
  1. 6.   Delayed onset of inherited ALS by deletion of the BDNF receptor TrkB.T1 is non-cell autonomous
  2. Yanpallewar,Sudhirkumar; Fulgenzi, Gianluca; Tomassoni Ardori,Francesco; Barrick,Colleen; Tessarollo,Lino
  3. EXPERIMENTAL NEUROLOGY. 2021, Mar; 337
  1. 7.   New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases
  2. Bensen, Ryan; Brognard,John
  3. International Journal of Molecular Sciences. 2021, Mar; 22(6):
  1. 8.   Oxygen Tension Regulates Lysosomal Activation and Receptor Tyrosine Kinase Degradation
  2. Hong,Jaewoo; Wuest, Todd R; Min,Yongfen; Lin,Charles
  3. Cancers. 2019, Nov; 11(11): pii: E1653..
  1. 9.   Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate Scaffolds
  2. Hogan, Megan; Bahta, Medhanit; Tsuji, Kohei; Nguyen, Trung X.; Cherry,Scott; Lountos,George; Tropea,Joseph; Zhao, Bryan M.; Zhao,Xue Zhi; Waugh,David; Burke,Terrence; Ulrich, Robert G.
  3. ACS COMBINATORIAL SCIENCE. 2019, Mar 11; 21: 158-170.
  1. 10.   Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers
  2. Nussinov,Ruth; Jang,Hyunbum; Tsai,Chung-Jung; Cheng, Feixiong
  3. PLoS computational biology. 2019, Mar; 15(3):
  1. 11.   Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2-d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors
  2. Romagnoli, Romeo; Prencipe, Filippo; Oliva, Paola; Baraldi, Stefania; Baraldi, Pier Giovanni; Schiaffino Ortega, Santiago; Chayah, Mariem; Kimatrai Salvador, Maria; Carlota Lopez-Cara, Luisa; Brancale, Andrea; Ferla, Salvatore; Hamel,Ernest; Ronca, Roberto; Bortolozzi, Roberta; Mariotto, Elena; Mattiuzzo, Elena; Viola, Giampietro
  3. JOURNAL OF MEDICINAL CHEMISTRY. 2019, Feb 14; 62(3): 1274-1290.
  1. 12.   Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
  2. Helman, Elena; Nguyen, Minh; Karlovich, Chris; Despain, Darrin; Choquette, A Karin; Spira, Alexander I; Yu, Helena A; Camidge, D Ross; Harding, Thomas C; Lanman, Richard B; Simmons, Andrew D
  3. Clinical lung cancer. 2018, Nov; 19(6): 518-530.e7.
  1. 13.   High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design
  2. Lountos, George; Raran-Kurussi, Sreejith; Zhao, Bryan M; Dyas, Beverly K; Burke, Terrence; Ulrich, Robert G; Waugh, David
  3. Acta crystallographica. Section D, Structural biology. 2018, Oct 01; 74(Pt 10): 1015-1026.
  1. 14.   Calmodulin and IQGAP1 activation of PI3K alpha and Akt in KRAS, HRAS and NRAS-driven cancers
  2. Nussinov, Ruth; Zhang, Mingzhen; Tsai, Chung-Jung; Jang, Hyunbum
  3. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2018, Jun; 0925-4439:(6, Part B, Special Issue): 2304-2314.
  1. 15.   Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B
  2. Thomas, Nicholas; Glod, John; Derse-Anthony, Claudia; Baple, Emma L; Obsborne, Nigel; Sturley, Rachel; Vaidya, Bijay; Newbold, Kate; Brooke, Antonia
  3. Clinical endocrinology. 2018, May; (5): 754-756.
  1. 16.   IL-7-induced phosphorylation of the adaptor Crk-like and other targets
  2. Aiello, Francesca; Guszczynski, Tad; Li, Wenqing; Jiang, Qiong; Hodge, Deborah; Massignan, Tania; Di Lisio, Chiara; Merchand, Anand; Procopio, Antonio D; Bonetto, Valentina; Durum, Scott
  3. Cellular Signalling. 2018, Mar 23; pii: S0898-6568(18)30073-1.
  1. 17.   Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
  2. Kraft, Ira L.; Akshintala, Srivandana; Zhu, Yuelin; Lei, Haiyan; Derse-Anthony, Claudia; Dombi, Eva; Steinberg, Seth M.; Lodish, Maya; Waguespack, Steven G.; Kapustina, Oxana; Fox, Elizabeth; Balis, Frank M.; Merino, Maria J.; Meltzer, Paul S.; Glod, John W.; Shern, Jack F.; Widemann, Brigitte C.
  3. CLINICAL CANCER RESEARCH. 2018, Feb 15; 24(4): 753-765.
  1. 18.   KIT Suppresses BRAF(V600E)-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling
  2. Neiswender, James V.; Kortum, Robert L.; Bourque, Caitlin; Kasheta, Melissa; Zon, Leonard I.; Morrison, Deborah; Ceol, Craig J.
  3. Cancer Research. 2017, Nov 01; 77(21): 5820-5830.
  1. 19.   Discovery and preclinical evaluation of 7-benzyl-N-(substituted)-pyrrolo [3,2-d]pyrimidin-4-amines as single agents with microtubule targeting effects along with triple -acting angiokinase inhibition as antitumor agents
  2. Pavana, Roheeth Kumar; Choudhary, Shruti; Bastian, Anja; Ihnat, Michael A.; Bai, Ruoli; Hamel, Ernest; Gangjee, Aleem
  3. BIOORGANIC & MEDICINAL CHEMISTRY. 2017, Jan 15; 25(2): 545-556.
  1. 20.   Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors
  2. Bahta, M.; Liu, F.; Kim, S. E.; Stephen, A. G.; Fisher, R. J.; Burke, T. R.
  3. Nature Protocols. 2012, Apr; 7(4): 686-702.
  1. 21.   Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy
  2. Logue, J. S.; Morrison, D. K.
  3. Genes & Development. 2012, Apr; 26(7): 641-650.
  1. 22.   Tamalin Is a Critical Mediator of Electroconvulsive Shock-Induced Adult Neuroplasticity
  2. Yanpallewar, S. U.; Barrick, C. A.; Palko, M. E.; Fulgenzi, G.; Tessarollo, L.
  3. Journal of Neuroscience. 2012, Feb; 32(7): 2252-2262.
  1. 23.   Non-SH2/PDZ reverse signaling by ephrins
  2. Daar, I. O.
  3. Seminars in Cell & Developmental Biology. 2012, Feb; 23(1): 65-74.
  1. 24.   Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296
  2. Langenkamp, E.; Zwiers, P. J.; Moorlag, H. E.; Leenders, W. P.; Croix, B. S.; Molema, G.
  3. Anti-Cancer Drugs. 2012, Feb; 23(2): 161-172.
  1. 25.   Eph/ephrin signaling in cell-cell and cell-substrate adhesion
  2. Singh, A.; Winterbottom, E.; Daar, I. O.
  3. Frontiers in Bioscience-Landmark. 2012, Jan; 17: 473-497.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel